COTA

Data analytics for cancer care improvement

New York City, New York, United States

About COTA

COTA Healthcare focuses on improving cancer care through technology and data analytics. They analyze real-world data related to oncology, which helps healthcare providers, researchers, and pharmaceutical companies make better decisions regarding patient treatment. COTA's solutions clarify fragmented data, providing actionable insights that aim to reduce variations in care quality and enhance patient outcomes. Unlike many competitors, COTA specifically targets the oncology sector and partners with various stakeholders in the cancer treatment ecosystem to deliver tailored insights. The company's goal is to ensure that every cancer patient receives the most appropriate and effective care possible.

New York City, New YorkHeadquarters

2011Year Founded

$73MTotal Funding

CONVERTIBLECompany Stage

Data & Analytics, HealthcareIndustries

201-500Employees

Risks

Over-reliance on AI could lead to inaccuracies if data isn't properly validated.

Multiple partnerships may lead to conflicts of interest or data privacy concerns.

Intensifying competition in oncology data analytics threatens COTA's market position.

Differentiation

COTA uses proprietary technology to organize complex oncology data for actionable insights.

Partnerships with companies like Guardant Health enhance COTA's precision oncology capabilities.

COTA's AI-powered curation engine, CAILIN™, transforms fragmented data into valuable insights.

Upsides

Growing AI adoption in healthcare aligns with COTA's precision oncology focus.

COTA's collaboration with the FDA strengthens its role in regulatory decision-making.

Partnerships with Caris Life Sciences expand COTA's multi-modal data offerings.

Funding

Total raised$72.95 M

Latest valuation$200.00 M

StageCONVERTIBLE

CONVERTIBLE

10/31/2020

Varian Medical Systems

$10

SERIES C

1/31/2018

$40

$200.00 M

SERIES B

11/30/2016

$18

$90.00 M

SERIES A

8/31/2014

$35.00 M